Correlation Between SAB Biotherapeutics and Biomarin Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SAB Biotherapeutics and Biomarin Pharmaceutical, you can compare the effects of market volatilities on SAB Biotherapeutics and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Biomarin Pharmaceutical.

Diversification Opportunities for SAB Biotherapeutics and Biomarin Pharmaceutical

-0.7

Correlation Coefficient

SAB Biotherapeutics  Biomarin Pharmaceutical

Excellent diversification

The 3 months correlation between SAB and Biomarin is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Biomarin Pharmaceutical go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and Biomarin Pharmaceutical

Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 13.22 times more return on investment than Biomarin Pharmaceutical. However, SAB Biotherapeutics is 13.22 times more volatile than Biomarin Pharmaceutical. It trades about 0.02 of its potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about 0.1 per unit of risk. If you would invest  7.74  in SAB Biotherapeutics on December 28, 2024 and sell it today you would lose (5.16) from holding SAB Biotherapeutics or give up 66.67% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	90.16%
Values	Daily Returns

SAB Biotherapeutics  vs.  Biomarin Pharmaceutical

SAB Biotherapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, SAB Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Biomarin Pharmaceutical

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Biomarin Pharmaceutical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Biomarin Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with SAB Biotherapeutics and Biomarin Pharmaceutical

The main advantage of trading using opposite SAB Biotherapeutics and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.

The idea behind SAB Biotherapeutics and Biomarin Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..